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Weight Gain Reveals Dramatic Increases in Skeletal
Muscle Extracellular Matrix Remodeling
Charmaine S. Tam, Jeffrey D. Covington, Sudip Bajpeyi, Yourka Tchoukalova,
David Burk, Darcy L. Johannsen, Cristina M. Zingaretti, Saverio Cinti, and
Eric Ravussin
Pennington Biomedical Research Center (C.S.T., J.D.C., S.B., Y.T., D.B., D.L.J., E.R.), Baton Rouge,
Louisiana 70808; The Charles Perkins Centre and School of Biological Sciences (C.S.T.), University of
Sydney, Sydney, 2006 New South Wales, Australia; Department of Kinesiology (S.B.), University of Texas
at El Paso, El Paso, Texas 79968; and Department of Experimental and Clinical Medicine-Obesity Center
(C.M.Z., S.C.), United Hospitals-University of Ancona, Ancona 60020, Italy
Context: In animal models of obesity, chronic inflammation and dysregulated extracellular matrix
remodeling in adipose tissue leads to insulin resistance. Whether similar pathophysiology occurs
in humans is not clear.
Objective: The aim of this study was to test whether 10% weight gain induced by overfeeding
triggers inflammation and extracellular matrix remodeling (gene expression, protein, histology) in
skeletal muscle and sc adipose tissue in humans. We also investigated whether such remodeling was
associated with an impaired metabolic response (hyperinsulinemic-euglycemic clamp).
Design, Setting, Participants, and Intervention: Twenty-nine free-living males were fed 40% over
their baseline energy requirements for 8 weeks.
Results: Ten percent body weight gain prompted dramatic up-regulation of a repertoire of ex-
tracellular matrix remodeling genes in muscle and to a lesser degree in adipose tissue. The amount
of extracellular matrix genes in the muscle were directly associated with the amount of lean tissue
deposited during overfeeding. Despite weight gain and impaired insulin sensitivity, there was no
change in local adipose tissue or systemic inflammation, but there was a slight increase in skeletal
muscle inflammation.
Conclusion: We propose that skeletal muscle extracellular matrix remodeling is another feature of
the pathogenic milieu associated with energy excess and obesity, which, if disrupted, may con-
tribute to the development of metabolic dysfunction. (J Clin Endocrinol Metab 99: 1749–1757,
2014)
Over the past 2 decades, the essential role of adiposetissue in whole-body energy homeostasis and met-
abolic health has been fully recognized. Due to its unique
ability to rapidly and dynamically expand and contract
through adipocyte hypertrophy and hyperplasia, adipose
tissue represents an important buffer both in terms of en-
ergy storage but, more importantly, metabolic health dur-
ing energy excess or deprivation (1). Adipose tissue re-
modeling is a continuous process, which is accelerated in
the obese state, leading to pathological features such as
impairedangiogenesis, localhypoxia, extracellularmatrix
overproduction and fibrosis, immune cell infiltration, and
chronic low-grade inflammation, all contributing to the
development of insulin resistance (1). Such pathological
disturbances have typically been described in individuals
with morbid obesity (2) and obese mouse models in which
a high-fat diet (60% calories as lard) provokes a nearly
complete remodeling of the epididymal fat depot (3). In
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contrast, studies in lean and overweight individuals after
less severe degrees of weight gain (4, 5) or loss (6) have not
demonstrated such profound pathological impairment.
Whether adipose tissue remodeling and fibrosis occurs af-
ter rapid weight gain in humans is not known.
In parallel with significant advances occurring in the
field of adipose tissue remodeling (1), there is growing
evidence that skeletal muscle, the major site for insulin-
stimulated glucose uptake, may be similarly adversely af-
fected. Acute lipid oversupply induces robust increases in
the expression of extracellular matrix (ECM) genes (col-
lagens, fibronectin, proteoglycans, connective tissue
growth factor) in the skeletal muscle of healthy individuals
(7). Furthermore, total collagen and collagens I and III are
higher in skeletal muscle from subjects with type 2 diabetes
and obese individuals (8). Supporting the role of muscle
extracellular matrix remodeling in the development of in-
sulin resistance, both insulin resistance and muscle colla-
gen (III and IV) deposition are rescued by pharmacological
or genetic manipulation targeting the extracellular matrix
in mice fed a high-fat diet (9, 10). It is not known whether
ECM remodeling in skeletal muscle occurs during weight
gain and is associated with development of insulin resis-
tance in humans.
The main purpose of this study was to examine whether
8-week overfeeding (40% above energy requirements) as
an experimental model to mimic early weight gain, in-
duces inflammation and extracellular matrix remodeling
in skeletal muscle and sc adipose tissue in free-living lean
to overweight healthy males and whether this response




Twenty-nine healthy, weight-stable males aged 20–40 years,
with a body mass index (BMI) (calculated as weight in kilograms
divided by height in meters squared) between 22 and 32 kg/m2,
were recruited from the Baton Rouge, Louisiana community us-
ing advertisements approved by an institutional review board.
Subjects were excluded if they reported a history of chronic dis-
ease (diabetes, heart or liver disease, high blood pressure, gas-
trointestinal disorder), recent weight loss or gain (2.5 kg over
the past 6 months), had abnormal blood or urine values or had
reported having a BMI of 32 kg/m2 or greater at any point in their
lifetime. This study was approved by the Pennington Biomedical
Research Center Institutional Review Board. All participants
provided written and informed consent before screening and
participation in the study (clinicaltrials.gov: identifier NCT
01672632).
Baseline weight stabilization and overfeeding
Prior to the 56-day overfeeding period, participants com-
pleted a 14-day measurement of free-living energy expenditure
by doubly labeled water (DLW) (11) to determine baseline en-
ergy requirements. During the second week of DLW participants
consumed an isocaloric diet (60% carbohydrate, 25% fat, 15%
protein). Baseline energy requirements were calculated as the
average of the measured 2-week energy expenditure by DLW and
the 1-week calorie level provided during feeding at weight main-
tenance and was multiplied by 1.4 to determine the overfeeding
prescription.
Diets
Diets were prepared by the metabolic kitchen and meals were
provided in a 5-day rotation with overfeeding calories in pro-
portion to run-in energy requirements (baseline energy require-
ment  1.4). Meals were comprised of 41% carbohydrate, 44%
fat, and 15% protein, and meal times were supervised by clinic
staff in the Inpatient Unit, Pennington Biomedical Research Cen-
ter to ensure that all foods were eaten.
Experimental procedures at baseline and after
overfeeding
Body composition and ectopic fat deposition
Body composition was measured using dual x-ray absorpti-
ometry (Hologic QDR 4500A whole body scanner), and scans
were analyzed with QDR software version 11.1 (Hologic). Ab-
dominal sc and visceral adipose tissue volumes were measured
using a 3.0 T scanner (Excite HD System; General Electric) by
obtaining 240–340 images from the highest point of the liver
through the pubic symphysis. Images were analyzed by a single
trained technician using Analyze software (AnalyzeDirect).
Hyperinsulinemic-euglycemic clamps
Insulin sensitivity was measured by a two-step hyperinsuline-
mic-euglycemic clamp. Insulin was infused for 180 minutes at 10
mU/minm2 (adipose/hepatic sensitivity), immediately followed
by 150 minutes at 50 mU/minm2 (skeletal muscle sensitivity).
Euglycemia (plasma glucose is 90 mg/dL) was maintained by
infusion of 20% dextrose enriched to 1% with [6,6-2H2]glucose.
The last 30 minutes of each insulin infusion dose was considered
the glucose infusion rate (GIR), expressed per kilogram of esti-
mated metabolic body size [GIR/fat-free mass (FFM)  17.7]
(12). From studies of metabolic rate in the Pima Indians, Lillioja
and Bogardus (12) showed that metabolic rate is directly pro-
portional to FFM  17.7 kg, suggesting that this measure can be
equated to metabolic size. The adjusted glucose disposal rate for
the low and high insulin dose are termed GIR1adj (10 mU) and
GIR2adj (50 mU).
Adipose and muscle tissue biopsies
Subcutaneous abdominal adipose and vastus lateralis muscle
tissue samples were obtained by percutaneous biopsy. Biopsy
sites were cleaned and draped. After anesthetizing the skin and
underlying tissues with lidocaine and bupivicaine, adipose tissue
was aspirated from the periumbilical area using a Bergstrom
needle, and vastus lateralis samples were collected using the
Bergstrom technique. Samples were immediately stored in fixa-
tive for immunohistochemistry or frozen in liquid nitrogen and
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stored at 80°C. Subsequent biopsies were obtained no less than
1 cm from the previous biopsy incision site, in compliance with
standard clinical practice at our center. Adipose tissue and skel-
etal muscle biopsies were available from 24 and 28 individuals,
respectively, at baseline and after overfeeding.
Analysis of skeletal muscle and adipose tissue
Isolation of mRNA and quantitative PCR
RNA was isolated using the miRNAeasy kit (QIAGEN) and
the yield determined by spectrophotometry (NanoDrop Tech-
nologies). From each RNA sample, 200 ng was reverse tran-
scribed to cDNA by using the high-capacity cDNA reverse tran-
scription kit (Applied Biosystems). Relative quantification of
mRNA expression was analyzed using ABI PRISM 7900 (Ap-
plied Biosystems) and custom Taqman gene expression micro-
fluidic cards (adipose) and Taqman gene expression assays (mus-
cle) for extracellular matrix and fibrosis-related genes
[(COL1a1, COL3a1, COL4a1, COL5a1, COL6a1, COL6a3,
SPARC, fibronectin, integrin X (complement component 3 re-
ceptor 4 subunit)], VEGF, TGF, SMAD2 and SMAD3) and
inflammation genes (CD68, IL6, NFkB, CCL2, adiponectin,
VCAM, TNF-). Primer details are listed in Supplemental Table
1. Samples were run in duplicate, and expression levels were
normalized to large ribosomal protein using the  cycle thresh-
old calculation method (adipose) or standard curve method
(muscle). In the adipose tissue and skeletal muscle, inflammation
gene expression was detectable in 75%–100% and 96%–100%
of available samples, respectively.
Protein analysis
For collagens 3 and 6 and CD68, 20 g protein per sample
was run on 4%–15% Criterion Tris-HCl gels (Bio-Rad Labora-
tories). For TGF3V, 40 g of protein per sample was run on
a10% SDS-PAGE gel (Bio-Rad Laboratories). Membranes were
incubated at 4°C overnight with antibodies against COL3 (Ab-
Cam; number 3829), COL6 (Santa Cruz Biotechnology;
SC-20649), CD68 (Abcam; ab31630), TGF3V (Santa Cruz
Biotechnology; SC-82), glyceraldehyde-3-phosphate dehydro-
genase (MCA2427; AbD Serotec), or -tubulin (2148; Cell Sig-
naling). The bands were visualized using the Odyssey 9120 in-
frared imaging system and quantified using Odyssey application
software, version 3.0 (LI-COR).
Histology and immunohistochemistry
Subcutaneous adipose biopsies were fixed in 4% paraformal-
dehyde, dehydrated, paraffin embedded, and sectioned (4 m).
Adipocyte size was measured using the osmium tetroxide
method as previously described (13). Cells were counted using
the Multisizer 3 Coulter Counter (Beckman Counter) using a
400-m aperture. Mean fat cell size was calculated from the
average of two runs (1000–3000 cells/run). To examine total
collagen content, Mallorys Trichrome staining and/or picro-
sirius red staining was performed. Picrosirius red staining was
performed using Polysciences, Inc. Picrosirius red stain kit
(24901–500) following the suppliers’ instructions on a Leica
automated slide stainer (ST5020). CD68 immunoreactivity was
examined on paraffin embedded sections using primary anti-
bodies against human CD68 (DAKO M0814, DK). All obser-
vations were performed with a Nikon Eclipse 80i light micros-
copy (Nikon). CD68 density was obtained by counting the total
number of CD68 macrophages in each section compared with
the total number of adipocytes (total adipocytes area per mean
adipocyte area) and expressed as CD68 macrophages per 1000
adipocytes.
Electron microscopy
Adipose tissue fragments were fixed in 2% glutaralde-
hyde-2% formaldehyde in 0.1 M phosphate buffer overnight,
postfixed in 1% osmium tetroxide, and resin embedded. Semi-
thin sections were stained with toluidine blue for choosing the
best area and thin sections were obtained with an MT-X ul-
tratome (RCM), counterstained with lead citrate, and examined
with a CM10 transmission electron microscopy (FEI).
Serum analysis
Plasma glucose concentrations during the clamp were mea-
sured using the YSI2700 STAT Analyzer (Yellow Springs Instru-
ments). Insulin and high-sensitivity C-reactive protein was mea-
sured by immunoassay with chemiluminescent detection
(Siemens; Immulite 2000XPi). Adiponectin and leptin were mea-
sured by a RIA (Millipore), and high-molecular-weight adi-
ponectin was measured by ELISA according to kit instructions
(Millipore). IL-6, IL-8, IL-10, IL-1, and TNF- were measured
on the Luminex LabMap100 (Millipore). TGF1 concentrations
were measured by ELISA according to the kit instructions (R&D
Systems).
Statistics
All analyses were performed using the Statistical Package for
Social Sciences (SPSS 20.0; SPSS Inc), and P values reported are
two tailed with statistical significance set at P  .05. Data are
presented as mean  SD. Comparisons before and after over-
feeding were examined using paired-samples t test and Wilcoxon
signed-rank test for normally and nonnormally distributed data,
respectively. Then we examined correlations between the fol-
lowing: 1) baseline body composition (body weight, fat mass,
and FFM, percentage fat, visceral and sc adipose tissue mass) and
insulin sensitivity (GIR1adj, GIR2adj) and baseline inflammation
and ECM markers (serum, adipose and muscle tissue), 2) base-
line inflammation and ECM markers and changes in body com-
position and insulin sensitivity; and 3) changes in ECM and in-
flammation markers and changes in body composition and
insulin sensitivity after overfeeding.
Results
Weight gain increased total and ectopic fat
deposition and impaired insulin sensitivity
Twenty-nine males (19 Caucasian, 10 African Ameri-
can, 26.8  5.4 y; BMI 25.5  2.3 kg/m2) completed 8
weeks of 40% overfeeding. Baseline energy requirements
were 3054  394 kcal/d, increasing to 4235  470 kcal/d
during overfeeding. Participants consumed an excess of
66156  9960 kcal/d above baseline requirements over
the 8-week period (range 42 476–80 052 kcal). The av-
erage weight gain was 7.6  2.1 kg (range 2.3–11.0 kg),
9.7%  2.8% of initial body weight (range 3–15%) of
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which 4.2  1.4 kg (55%) consisted of fat and 3.4  1.5
kg (45%) consisted of FFM. Abdominal adipose tissue
volume increased by 31% in the sc depot and 62% in the
visceral depot. Fasting glucose levels were not different
after overfeeding. However, glucose infusion rate (ad-
justed for estimated metabolic size) during a hyperinsu-
linemic-euglycemic clamp significantly decreased during
both the low (10 mU/minm2; 2.87  0.94 to 2.35  0.75
mg/kgmin; P  .001) and the high insulin infusion (50
mU/minm2; 11.51  2.54 to 10.91  2.46 mg/kgmin,
P  .05), indicating overfeeding-induced insulin resis-
tance. There was no change in physical activity level, cal-
culated using total daily energy expenditure (DLW) di-
vided by 24-hour energy expenditure (metabolic
chamber), after overfeeding (data not shown). Changes in
body composition and metabolic health are summarized
in Table 1.
Dramatic increases in ECM remodeling in both
skeletal muscle and adipose tissue
To investigate whether weight gain induced alterations
in the ECM of skeletal muscle and adipose tissue, we mea-
sured ECM remodeling genes associated with tissue ar-
chitecture, cell adhesion and angiogenesis. We found a 4-
to 30-fold increase in mRNA levels of a range of collagens
(COL1, COL3, COL4, COL5, COL6) and ECM genes
(Figure 1A) including secreted protein acidic and rich in
cysteine (SPARC) and integrin-X. COL3 and COL6 pro-
tein levels were unchanged (Supplemental Figure 1). These
results demonstrate robust up-regulation of ECM remod-




Anthropometry and body composition
Weight, kg 81.9  10.3 89.5  9.4a
Waist circumference, cm 84.6  6.6 92.0  7.2b
Body fat, % 19.4  4.9 22.3  5.2b
Fat mass, kg 16.0  4.8 20.2  5.6b
FFM, kg 65.9  7.3 69.4  7.3b
Subcutaneous adipose
tissue, kg
4.1  1.5 5.4  1.8b
Visceral adipose tissue,
kg
0.58  0.49 0.94  0.58b
Insulin sensitivity
Fasting insulin, U/mL 5.4  4.0 8.3  7.8a
Fasting glucose, mg/dL 91.0  6.7 92.7  6.9
GIR, mg/min(FFM 
17.7)
Insulin infusion at 10
mU/minm2
2.87  0.94 2.35  0.75b
Insulin infusion at 50
mU/minm2
11.51  2.54 10.91  2.46a
Serum metabolic markers
Triglycerides, mg/dL 87  42 96  68
Free fatty acids, nmol/L 0.26  0.08 0.30  0.11
Total cholesterol, mg/dL 171  25 196  31b
HDL to LDL ratio 0.59  0.20 0.50  0.16b




0.6 (0.3–1.7) 0.7 (0.5–1.6)
Total adiponectin, g/mL 3.6 (1.1–3.6) 4.5 (2.2–7.1)
High-molecular-weight
adiponectin, ng/mL
8352 (4724–9653) 8746 (4514–12865)
TNF-, pg/mL 6.6 (4.4–7.8) 6.8 (4.8–8.0)
IL-6, pg/mL 1.01 (0.7–1.6) 1.2 (0.5–2.3)
IL-8, pg/mL 4.8 (4.1–6.3) 5.4 (3.6–6.7)
IL-10, pg/mL 9.4 (6.9–13.1) 10.0 (6.0–18.0)
HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol. Data are presented as mean  SD or median (interquartile
range).
a P  .001.
b P  .05.
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eling gene expression in skeletal muscle after overfeeding.
The changes in skeletal muscle ECM mRNA levels (COL1,
COL3, COL4, COL5, COL6, SPARC) were highly posi-
tively associated with changes in inflammation mRNA
levels (CD68, CCL2) (all P  .001, r2 	 0.8–0.9; data not
shown).
Consistent with previous studies (5), weight gain also
induced significant increases in ECM remodeling (COL1,
COL3, and SPARC) in sc adipose tissue (Figure 1B). Picro-
sirius staining for total collagen content in adipose tissue
was unchanged after weight gain, potentially explained by
loss of ECM architecture using the needle biopsy tech-
nique, compared with biopsy samples excised during sur-
gery (14) (Figure 1C). We saw no evidence of pericellular
fibrosis in our samples at baseline or after overfeeding.
There were no significant correlations between mRNA
levels of ECM markers in skeletal muscle and adipose tis-
sue with measures of body composition and metabolic
health at baseline.
Pathological markers of fibrosis in muscle
Given the striking increases in muscle ECM remodeling
in response to overfeeding, we evaluated whether the
TGF signaling pathway, the canonical pathway of fibro-
sis, was similarly up-regulated. After weight gain, TGF
mRNA levels were 2-fold higher (P 	 .04) with a trend
toward increased phosphorylated mothers against deca-
pentaplegic (SMAD)-3, (P 	 .08). No differences were
observed in SMAD2 expression (Figure 1D). Protein levels
of muscle TGF were slightly decreased (P 	 .01), and
circulating TGF concentrations were unchanged after
overfeeding (Supplemental Figure 1). There was a positive
association between the change in COL3 and TGF pro-
tein levels (P 	 .03, r2 	 0.46).
Figure 1. Skeletal muscle and adipose tissue ECM remodeling and fibrosis gene expression and histology before and after overfeeding. Muscle
ECM remodeling mRNA levels (COL1a1, COL3a1, COL4a1, COL5a1, COL6a1, COL6a3, SPARC) were dramatically up-regulated after overfeeding.
Integrin alpha X mRNA levels were unchanged (A). Similarly, in sc adipose tissue, we saw significant increases ECM remodeling genes (COL1a1,
COL3a1, SPARC, TGF) after overfeeding (B). Picrosirius red staining for collagen in sc adipose tissue in representative samples from a male at
baseline and after overfeeding and a morbidly obese positive control showed no difference in collagen staining (C). In muscle, TGF mRNA levels,
a classical marker of fibrosis, was significantly increased after overfeeding, but there were no effects on downstream signaling of SMAD2 or
SMAD3 (D). Unfilled and filled bars represent baseline and postoverfeeding values. **, P  .001; *, P  .05.
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Raised inflammation in skeletal muscle but not
adipose tissue after weight gain
After overfeeding, CD68 (P 	 .01), CCL2 (P 	 .02),
and CD40 (P 	 .02) mRNA levels were 2-fold higher and
nuclear factor-B (NFB) mRNA levels were 4-fold higher
(P 	 .01) in skeletal muscle; there was no change in muscle
TNF- expression (Figure 2A). Inflammation, as mea-
sured by CD68, IL6, CCL2, adiponectin, NFB, and vas-
cular cell adhesion molecule mRNA expression levels, was
unchanged in sc adipose tissue despite 10% body weight
gain (Figure 2B). Supporting our gene expression data, we
observed sparse numbers of CD68 macrophages and
few crown-like structures in adipose tissue before and af-
ter overfeeding (Figure 2C). Intravascular inflammation
was evidenced by neutrophils located inside blood vessels
in three males prior to overfeeding (Supplemental Figure
2). However, no intravascular inflammation was seen af-
ter overfeeding. As expected, sc abdominal fat cell size
increased after overfeeding (0.76  0.40 to1.06  0.33
nL; P  .001). Circulating high-sensitivity C-reactive pro-
tein, total and high-molecular-weight adiponectin,
TNF-, IL-6, IL-8, and IL-10 concentrations were not al-
tered by overfeeding and were detectable in 97%–100%
of samples. IL-1 concentrations were not detectable at
baseline or after overfeeding (Table 1). At baseline, the
amount of visceral adipose tissue positively correlated
with CD68 (P 	 .002, r2 	 0.62) and NFb mRNA levels
(P 	 .013, r2 	 0.54) in adipose tissue.
Associations between ECM and inflammation
markers at baseline and the metabolic response to
overfeeding
Next, we evaluated whether baseline ECM and inflam-
mation markers in muscle, adipose tissue or systemic cir-
culation were associated with adverse metabolic responses
with overfeeding. In skeletal muscle, baseline mRNA lev-
els of a wide range of ECM remodeling genes (COL1,
COL3, COL4, COL5, SPARC, integrin) were positively
associated with the change in FFM (absolute and percent-
age change) after overfeeding, suggesting that skeletal
muscle ECM may play a critical role during energy excess
(Figure 3). Interestingly, TGF mRNA levels showed the
inverse association. There were no associations between
ECM and inflammation markers in muscle, adipose tissue,
or the circulation and changes in insulin sensitivity after
overfeeding.
Discussion
Our data demonstrated that rapid weight gain coupled
with impaired insulin sensitivity in healthy young males
(7.6  2.1 kg in 8 wk) prompted robust increases in a
Figure 2. Skeletal muscle and adipose tissue inflammation gene
expression before and after overfeeding. Inflammation (CD68, CCL2,
CD40, NFkB) mRNA levels in vastus lateralis were significantly increased
after 8 weeks of overfeeding (A) but were unchanged in sc abdominal
adipose tissue (B). Unfilled and filled bars represent baseline and
postoverfeeding values; *, P  .05. Light microscopy of CD68
macrophages were located in a crown-like structure in adipose tissue.
This picture is of one of the few crown-like structures observed in the
current study (C).
Figure 3. Correlations between muscle ECM gene mRNA levels prior to overfeeding and change in FFM. We saw significant associations between
muscle COL1a1, COL3a1, COL4a1, COL5a1, SPARC, and integrin mRNA levels and the absolute change in FFM (kilograms).
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repertoire of extracellular matrix remodeling genes in
skeletal muscle and to a lesser degree in sc adipose tissue.
To our knowledge, this is the first time that skeletal muscle
ECM remodeling has been documented after weight gain
in humans. Skeletal muscle ECM mRNA levels prior to the
intervention were directly associated with the amount of
FFM gained during overfeeding, highlighting the signifi-
cance of skeletal muscle extracellular matrix in potentially
buffering nutrient excess and maintaining energy homeo-
stasis. Interestingly, despite this large weight gain in
healthy male volunteers, there was no evidence of local
adipose tissue or systemic inflammation, complementary
to findings in previous overfeeding studies in humans (4,
5) and rodent models of high-fat feeding (15).
Robust increases in skeletal muscle ECM
remodeling after overfeeding
The ECM is essential for tissue architecture and regu-
lating intercellular communication. ECM accumulation
leads to fibrosis in a wide variety of tissues, which may
irreversibly alter the structure and function of affected
tissues and whole-body homeostasis. Our data revealed
robust increases in a repertoire of muscle ECM remodeling
genes but little changes in classical pathways of fibrosis
after weight gain, nor did we replicate our gene expression
findings at the protein level. These findings suggest that
ECM remodeling in muscle may be indicative of a phys-
iological response related to short-term energy excess, as
opposed to a pathological fibrotic response as seen in
chronic fibrotic diseases in the liver, kidney (16), and more
recently described obese adipose tissue (17).
The ECM in skeletal muscle provides an important role
in muscle fiber force transmission, maintenance, and re-
pair (18), and defects in key ECM components can lead to
loss of physical function such as in muscular dystrophy
conditions (19). There is growing evidence that muscle
ECM remodeling has a unique role contributing to muscle
insulin resistance (7–10). In high-fat fed mice with insulin
resistance and higher muscle collagens III and IV, rescue of
muscle insulin resistance by genetic muscle-specific cata-
lase overexpression or pharmacological treatment re-
versed high-fat feeding effects on ECM remodeling, dem-
onstrating that muscle ECM collagen expansion and
muscle insulin resistance are tightly associated (9). Further
mechanistic insight is provided by studies in integrin 21-
null mice, in which the link between muscle insulin resis-
tance and increased collagen is uncoupled (9). In addition,
high muscle collagen content is characteristic of insulin-
resistant muscle in obese individuals and in subjects with
type 2 diabetes (8).
Interestingly, similar to adipose tissue (20–22), there
appears to be a close interplay between ECM and inflam-
mation in skeletal muscle evidenced by the significant as-
sociations between changes in gene expression of ECM
remodeling genes after overfeeding and changes in inflam-
mation genes. The evidence from our study and previous
studies (9, 10) suggest a key role for muscle ECM in reg-
ulating muscle metabolism. Although we did not see as-
sociations between skeletal muscle ECM and impaired in-
sulin sensitivity in the relatively lean and healthy males in
the current study, we speculate that dysregulated muscle
ECM may be another feature of the pathogenic milieu
contributing to the development of insulin resistance and
type 2 diabetes. Indeed, it is well known that diabetes
deteriorates muscle contractibility and induces muscle at-
rophy, although the underlying mechanisms are unclear
(23). The ability of the muscle ECM to adapt to energy
excess may be a mediator influencing muscle metabolism.
Evidence of ECM remodeling but no inflammation
in adipose tissue after overfeeding
In recent years, it has been well described that ECM
remodeling is crucial for adipogenesis and adipose tissue
growthand that excessiveECMaccumulation (ie, fibrosis)
is a hallmark of sc and visceral adipose tissue in obese
humans (1). Furthermore, sc adipose tissue fibrosis in
obese individuals persists, even after bariatric surgery-in-
duced loss weight loss (20, 22). The importance of the
ECM in regulating whole-body energy homeostasis is
demonstrated by studies in COL6/ mice, which have
demonstrated uninhibited adipose tissue expansion with-
out impaired metabolic responses when on a high-fat diet
or on an ob/ob background (17). In the present study, we
observed consistent increases in mRNA levels of collagens
I and III, SPARC, and TGF, suggesting that sc adipose
tissue in healthy lean males is remodeled to adapt to energy
excess. Notably, despite 10% of body weight gain and
decreased peripheral insulin sensitivity, we did not ob-
serve any evidence of systemic or local sc adipose tissue
inflammation after overfeeding; we cannot comment on
the potential influence of visceral adipose tissue.
Our results, in conjunction with findings from previous
overfeeding studies in humans (4, 5, 24) and rodents (15),
strongly suggest that adipose tissue inflammation may oc-
cur secondary to weight gain and insulin resistance in hu-
mans. Furthermore, our data lend support to the hypoth-
esis that the initiation and propagation of adipose tissue
low-grade inflammation may require repeated bouts of
energy excess over an extended period to time to reach a
critical threshold where such an inflammatory response is
maintained (25). Indeed, weight cycling in mice enhances
the inflammatory response in adipose tissue and in the
circulation, which may contribute to metabolic dysfunc-
tion (26, 27). It may also be that adipose tissue inflam-
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mation contributes more toward the maintenance and ex-
acerbation of insulin resistance once it is initiated (15, 28).
Strengths and limitations
A main strength of our study was the rigorously con-
trolled feeding protocol. During the intervention, all meals
were prepared by the metabolic kitchen and consumed
under supervision at our research center. Second, our
study used gold standard techniques for measuring insulin
sensitivity (hyperinsulinemic-euglycemic clamp) and also
DLW for determining energy requirements during energy
balance and overfeeding. Possible limitations may be that
the interpretation of our findings are limited to sc adipose
tissue; the dynamics of the inflammatory and ECM re-
sponse in other fat depots, particularly visceral adipose
tissue, cannot be addressed in this study. Despite robust
increases in mRNA levels of ECM remodeling genes in
muscle, we did not see changes in protein levels of colla-
gens 3 and 6, indicating that there could be either increased
synthesis or decreased degradation by matrix metallopro-
teinases; this was not able to be addressed in the current
study due to the small size of the muscle biopsy. Further-
more, it would be interesting to measure factors that reg-
ulate muscle growth such as myostatin, activins, and fol-
listatin in future studies.
In conclusion, results from our overfeeding study pro-
vide unique insights into skeletal muscle and adipose tissue
dynamics after 10% body weight gain in healthy, lean
males. We have uncovered a novel facet of the skeletal
muscle response to weight gain, demonstrating robust in-
creases in extracellular matrix remodeling genes that are
directly associated with the amount of lean tissue mass
deposited during overfeeding. There is no doubt that our
findings trigger many further questions and future inves-
tigations addressing the regulation and cellular composi-
tion of the muscle extracellular matrix are required to
elucidate the potential significance of the skeletal muscle
ECM in regulating insulin resistance and whole-body ho-
meostasis and function.
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